Skip to main content

Balchem (NASDAQ: BCPC) — Company Overview, News & Financial Data

Balchem  logo
BCPC Balchem
Balchem  primary media
Company profile

Balchem

Balchem (NASDAQ:BCPC) specializes in the development, manufacturing, and marketing of specialty performance ingredients and products for the nutrition, food, and pharmaceutical industries. With a strong emphasis on science and innovation, Balchem's projects span a variety of applications, from nutrition and health to food, beverage, and pharmaceuticals, aiming to improve consumer health and wellbeing. Its strategic objective is to enhance product performance while maintaining a commitment to safety and sustainability. Balchem's efforts to continuously expand its product range and explore new markets reflect the company's dedication to meeting the evolving needs of customers worldwide, making it a key player in the sectors it serves.

Snapshot

Public USOwnership
1967Year founded
770Employees
New Jersey, United StatesHead office
Loading Map...
Global footprint

Operations

All Locations
United States

Products and/or services of Balchem

  • Encapsulated nutrients for feed efficiency and health in animal nutrition, promoting productivity and wellbeing.
  • Specialty gases for medical and industrial applications, including nitrous oxide and carbon dioxide.
  • Choline chloride and derivatives for human nutrition, supporting brain development and liver function.
  • Chelated minerals for improved nutrient uptake in both human health supplements and animal feeds.
  • Food grade phosphates for meat processing, enhancing flavor, tenderness, and shelf life.
  • Propylene oxide used for sterilizing spices, ensuring safety and quality in food production.

Balchem executive team

  • Theodore Lee HarrisCEO, President & Chairman
  • Carl Martin BengtssonExecutive VP, CFO, Treasurer and GM of Animal Nutrition & Health
  • Hatsuki MiyataExecutive VP, Chief Legal Officer & Secretary
  • M. Brent TignorSenior VP & Chief Human Resources Officer
  • Frederic BonedSenior VP, Head of Digital Transformation & AI and GM of Human Nutrition & Health
  • Erin L. GilsonVP & Chief Accounting Officer
  • Martin Luther ReidSenior VP & Chief Supply Chain Officer
  • Job L. van GunsterenSenior VP & GM of Specialty Products
  • George GrahamSenior VP and Chief R&D Officer

Dividend history

Dividends per share paid by Balchem , by financial year.

Balchem dividends per share by financial year
Financial yearInterimFinalSpecialTotal
FY2026(to date)———$0.3984
FY2025———$0.9600
FY2024———$0.8700
FY2023———$1.1884
FY2022———$0.7100

Key financials

Reported results for Balchem , in USD.

Market cap
5.3B
Revenue (TTM)
1.1B
P/E ratio
31.4
EPS (diluted, TTM)
5.3
Dividend yield
0.6%
Profit margin
15.4%
Balchem annual revenue and income
Fiscal year endRevenueOperating incomeNet income
1B218.3M154.8M
953.7M182.9M128.5M
922.4M159.2M108.5M
942.4M145.2M105.4M